Biotheranostics Announces Inclusion of Breast Cancer Index in the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines for Prediction of Benefit from Extended Endocrine Therapy
19 janv. 2021 08h00 HE
|
Biotheranostics, Inc.
San Diego, CA, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Breast Cancer Index™ (BCI) has reached an incredible milestone as a new standard of care to predict benefit from extended endocrine therapy for...
Biotheranostics Launches Not Another Minute Campaign for its Breast Cancer Index® Test
11 déc. 2019 08h00 HE
|
Biotheranostics, Inc.
San Diego, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces the launch of its Not Another Minute campaign, revealing how Breast Cancer Index (BCI) is changing the game for...